baber/WOPTO huggingface dataset:
Patent CA-2604412-A1 (CA)
Title: Method and system for providing deal-making in multiplayer tournaments
Inventor: KUMAR RIPUL
IPC: G06Q50/00
Filed: 2007-09-27
Abstract: A system and method for deal-making in a multiplayer game-of-chance tournament are described. The system and method are applicable to poker, blackjack, mah-jongg, video slots, and other betting games of chance at online and live casinos. The system includes a graphical interface which depicts the game-of-chance and a deal--making interface. The deal-making interface allows players to negotiate the distribution of a divisible prize (a prize pool split). The graphical interface may also include a chat window, displayed along with the deal-making interface, for allowing communication among players.
Patent CA-2607910-A1 (CA)
Title: Porte comportant des moyens de detection d'obstacle munis d'un connecteur forme de deux parties detachables
Inventor: KRAEUTLER BERNARD
IPC: H02G11/00
Filed: 2006-05-22
Abstract: La porte comprend d'une part un cadre et d'autre part un tablier (4) déplaçable par des moyens d'entraînement entre une position fermée et une position ouverte. Le tablier comporte des moyens de détection d'obstacles reliés par un câble (20) à un dispositif de commande des moyens d'entraînement. Une première extrémité (21) du câble est associée au tablier, la deuxième extrémité (22) étant associée au cadre. La première et/ou la deuxième extrémité du câble comprend un connecteur (19, 23) monté sur une zone du tablier ou du cadre de façon mobile en rotation autour d'un axe (26, 34) perpendiculaire à ladite zone et pouvant être séparé, sous l'effet d'une traction, en deux parties reconnectables. Ainsi, il est possible de détacher une extrémité du câble du tablier ou du cadre.
Patent CA-2611215-A1 (CA)
Inventor: DE OJEDA WILLIAM
IPC: F02B37/18
Filed: 2007-11-19
Abstract: When a high-pressure compressor stage operates in an efficient operating zone defined on a compressor performance to one side of an optimum performance line that is spaced from but generally parallel to a choke limit line, the turbocharger is controlled by closed-loop control of vanes of the high-pressure turbine stage while a by-pass around the high-pressure turbine stage is kept closed.  When the high-pressure compressor stage operates in a zone between the optimum performance line and the choke limit line, the vanes of the high-pressure turbine stage are increasingly opened as operation of the high-pressure compressor stage increasingly approaches the choke limit line. When the vanes have been maximally opened and the high-pressure compressor stage has become unable to provide sufficient boost, the high-pressure turbine by-pass is opened to begin routing exhaust flow to a low-pressure turbine that operates a low-pressure compressor stage, thereby avoiding choking of the charge air flow by the high--pressure compressor stage.
Patent CA-2611413-A1 (CA)
Inventor: CHOPSKIE HELTEMES JOCELYN H
IPC: A23L3/3463
Filed: 2006-07-12
Abstract: The present invention relates to a method of using an antimicrobial composition on a food product where the antimicrobial composition is applied to a food product, the food product is packaged and sealed, and then activation energy is applied to the sealed food product.
Patent CA-2612721-A1 (CA)
Inventor: HAUSHEER FREDERICK H
IPC: C07F15/00
Filed: 2006-01-26
Abstract: Disclosed herein are novel platinum-based complexes possessing one nitrile substituent group (mononitrile) covalently-bonded to the platinum, one or more nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA  or RNA and leaving groups (i.e., L1 and L2 )which can be hydrolyzed in vivo to active species, which can then form coordinate adducts with DNA or RNA at the Guanine or Adenine bases thereof. Also disclosed herein are the reaction schemes for the synthesis of said platinum complexes, as well as methods of treatment of various types of cancer by the administration of a pharmaceutically-effective dose of said novel platinum complexes.
Patent CA-2613650-A1 (CA)
Title: Access point and method for delivering information on media independent handover protocol
Inventor: PARK SOO-HONG
IPC: H04L12/28
Filed: 2006-06-27
Abstract: An apparatus and method relates to transmission of media independent (MIH) handover protocol information, the access point includes a wired interface module to receive, through a wired network, indication information indicating whether an access point that manages a neighboring heterogeneous subnet supports a protocol to conduct a media independent handover (MIH), a storage module to store the received indication information, a frame generating module to generate a frame including the stored indication information, and a wireless interface module to transmit the generated frame to a mobile node.
Patent CA-2613705-A1 (CA)
Title: Compositions and methods for less immunogenic pr0tein-lip1d complexes
Inventor: STRAUBINGER ROBERT M
IPC: A61K35/14
Filed: 2006-06-29
Abstract: The present invention provides compositions and methods for reducing the immunogenicity and increasing the circulating half-life of therapeutic proteins such as Factor VIII. The compositions comprise lipidic structures such as liposomes, micelles and cochleates comprising a negatively charged lipid and polyethylene glycol derivatized phospatidyl ethanolamine.
Patent CA-2614274-A1 (CA)
Inventor: BERG CASPER TUNE
IPC: A23L29/00
Filed: 2006-07-07
Abstract: We describe a PS4 variant polypeptide derivable from a parent polypeptide having amylase activity selected from the group consisting of: (a) a polypeptide comprising an amino acid mutation at each of positions 33, 34, 121, 134, 141, 146, 157, 161, 178, 179, 223, 229, 272, 303, 307, 309 and 334;  (b) a polypeptide comprising an amino acid mutation at each of positions 33, 34, 121, 134, 141, 145, 146, 157, 178, 179, 223, 229, 272, 303, 307 and 334;  (c) a polypeptide comprising an amino acid mutation at each of positions 33, 34, 121, 134, 141, 146, 157, 178, 179, 223, 229, 272, 303, 307, 309 and 334;  and (d) a polypeptide comprising an amino acid mutation at each of positions 3, 33, 34, 70, 121, 134, 141, 146, 157, 178, 179, 223, 229, 272, 303, 307, 309 and 334; with reference to the position numbering of a Pseudomonas saccharophilia exoamylase sequence shown as SEQ ID NO: 1 , uses of such a polypeptide as a food or feed additive, and nucleic acids encoding such.
Patent CA-2614507-A1 (CA)
Title: Immune cell biosensors and methods of using same
Inventor: CRAWFORD KRITH D
IPC: G06F19/00
Filed: 2005-07-11
Abstract: The present invention relates to immunological cells that are useful in detecting changes in physiological states, which provide for methods of diagnosing diseases or monitoring the course of patient therapy. Also provided are arrays of antigen presenting cell-specific markers for detecting changes in physiological states, and methods of detecting such changes.
Patent CA-2615843-A1 (CA)
Inventor: AUBRY FLORENCE
IPC: G05D1/06
Filed: 2006-07-25
Abstract: A method and device for detecting a risk of collision of an aircraft, having a profile unit having knowledge of the terrain profile, a determination unit for determining effective values of particular flight parameters, a checking unit for verifying whether a flight path determined by the effective values is compatible with the terrain profile, and a transmitting unit for emitting a warning signal in case of incompatibility. The checking unit includes at least one element for calculating a height variation due to an energy transfer and a total slope variation generated by a speed reduction, during an evasive action, an element deter mining an evasive course using the height variation, and an element verifying whether the evasive course determined is compatible with the terrain profile.
Patent CA-2617299-A1 (CA)
Inventor: DEVILLE DEREK DEE
IPC: A61B17/00
Filed: 2006-07-25
Abstract: A medical device (1000) comprises a laparoscopic shaft (226, 1110, 1130) having proximal and distal ends and defining a shaft axis, a surgical end effector (1002, 1020, 1030, 1040) at the distal end of the shaft (226, 1110, 1130), a locking device (120, 1120) operable to selectively unlock the end effector (1002, 1020, 1030, 1040) when actuated, and a rotating knob (1100) at the proximal end of the shaft (226, 1110, 1130). The rotating knob (1100) comprises a bias device that imparts a biasing force on the rotating knob (1100) in a distal direction, the rotating knob (1100) rotating the end effector (1002, 1020, 1030, 1040) with respect to the shaft (226, 1110, 1130) about the shaft axis when rotated, and actuating the locking device (120, 1120) when slid in a proximal direction to overcome the biasing force.
Patent CA-2617353-A1 (CA)
Inventor: SANCHEZ-GARCIA ISIDRO
IPC: A61K39/00
Filed: 2006-07-28
Abstract: The invention relates to the graded expression level of SNAIL gene or its expression products, as a marker of the capacity of epithelial and mesenchymal tumours and/or cancers for disseminating to other tissues or organs. The invention further relates to a transgenic non-human mammal comprising in its genome a transgene that comprises a nucleic acid sequence encoding the SNAIL  protein, and the use of SNAIL as a marker of epithelial and mesenchymal tumours and/or cancers as well as in DNA damage-based diseases In addition, the invention relates to the use of SNAIL as a therapeutic and diagnostic target for said pathologies.
Patent CA-2618437-A1 (CA)
Inventor: OHAYON SALOMON SYDNEY
IPC: B60R25/00
Filed: 2006-08-15
Abstract: A vehicle security system for securing a vehicle against theft, the system comprising, a driving function disablement component configured to bias against a moveable vehicle component, thereby to disable a driving function when biased, a remotely operable transducer configured to maintain or release biasing in the driving function disablement component, and a wireless handheld transceiver configured to transmit a wireless drive-activating signal to operate the transducer.
Patent CA-2619951-A1 (CA)
Inventor: SCHENK JOHN L
IPC: C12N5/076
Filed: 2006-07-24
Abstract: The inventive technology relates to methods and apparatus for reducing prote in content in sperm cell extenders and may include one or more of the following features: techniques for reducing protein content in a sperm cell extender; techniques for reducing protein content in a cryoprotectant-containing B fraction of a sperm cell extender; techniques for preparing sperm cell extenders that do not require clarification; techniques for preparing low density gradient sperm cell extenders suitable for centrifugation; technique s for reducing protein content between individual steps in preparing a sperm cell extender, and techniques for establishing novel values of reduced prote in content in sperm cell extenders.
Patent CA-2621876-A1 (CA)
Title: Synergistic mixtures
Inventor: BRUNS RAINER
IPC: B27K3/50
Filed: 2006-08-29
Abstract: The novel synergistic mixtures based on triadimefon and/or triadimenol and known insecticides are highly suitable for protecting commercial materials, in particular timber and wood materials, in addition to wood-plastic composites from being attacked, damaged and/or destroyed by biological pests.
Patent CA-2623012-A1 (CA)
Inventor: PFAHLERT ROGER
IPC: E21B7/24
Filed: 2006-09-21
Abstract: Vertical and/or directional drilling apparatus where compliant support (air bag, magnetic or the like) is provided for a vibrational head and drive assembly that carries the drill string. With the vibrational head having a shuttle from which vibration is not directly taken and with the compliant support allowing pull back in the directional mode several advantages arise.
Patent CA-2624663-A1 (CA)
Inventor: RAGHUNATHAN NARAYAN
IPC: B65F1/02
Filed: 2008-03-07
Abstract: A refuse container comprising: a container assembly including a bin defining a cavity, a lid rotatably coupled to the bin, and configured for movement, relative to the bin, between an open position providing access to the cavity, and a closed position inhibiting access to the cavity, and a locking mechanism including a latch including a handle, and moveable between a locked position and an unlocked position, a detent acting between the bin and the lid, and co-operating with the latch so as to effect locking of the lid to the bin when the latch is in the locked position, and permit movement of the lid, relative to the bin, from the closed position to the open position when the latch is in the unlocked position, wherein the latch is configured to move from the locked position to the unlocked position in response to application of an unlocking force to the handle, and wherein, when the latch is disposed in the unlocked position and the lid is disposed in the closed position, the lid is configured to move from the closed position to the open position in response to an application of a lid-opening force to the handle, and wherein the unlocking force includes a horizontal component and a vertical component, and wherein the lid-opening force includes a horizontal component and a vertical component, and wherein the direction of the horizontal component of the lid-opening force is disposed at an angle of between about 90 degrees and about 270 degrees in a clockwise direction about a vertical axis and relative to the direction of the horizontal component of the unlocking force.
Patent CA-2625737-A1 (CA)
Inventor: DALY CLYDE CHARLES
IPC: A23L5/41
Filed: 2005-10-14
Abstract: A method of maintaining a desirable fresh and/or healthy appearance of a cut of meat during retail display including the steps of maintaining said cut of meat at a temperature within a temperature range as close to freezing as possible without freezing said meat following cutting of said meat from a meat primal; and maintaining said meat at said temperature in an oxygenated environment for a predetermined extended period of time before transfer to a retail display temperature.
Patent CA-2626586-A1 (CA)
Inventor: STEFANSSON STEFAN EINAR
IPC: C07D243/00
Filed: 2006-10-27
Abstract: This invention relates to a stable pharmaceutical formulation containing olanzapine. The composition comprises olanzapine or a pharmaceutically acceptable salt thereof, one or more suitable pharmaceutical excipients and a compound of formula (I) and/or a compound of formula (II): or a pharmaceutically acceptable salt thereof.
Patent CA-2627921-A1 (CA)
Inventor: PATTON ERIC
IPC: B60R13/08
Filed: 2006-10-23
Abstract: A panel structure (300) and a method of forming the panel structure (300) are disclosed. The panel structure (300) typically includes at least one panel (302, 304) or support (306) associated with an activatable material (310). The panel structure (300) has been found particularly advantageous for use as an interior panel of an airplane although multiple other uses are contemplated as well.
Patent CA-2628156-A1 (CA)
Inventor: KULLANDER JOAKIM
IPC: G05D24/02
Filed: 2006-10-30
Abstract: The invention relates to a transmitter for consistency measuring of pulp suspensions at first hand, comprising a measuring body (1), shaped such as a blade, suspended in a vibration-producing apparatus. The measuring body (1) shaped such as a blade (I' ) shows wave-shaped side surfaces (9, 10) in its transverse direction and is vibratable in a frequency of oscillation between 20-80 Hz and with a predetermined amplitude of +/- 2-8 mm, that provides a combination of both shearing force measurement and a measurement of the resistance of conveyance of liquid through a fibre netting.
Patent CA-2630785-A1 (CA)
Title: Ionic liquid containing phosphonium cation having p-n bond and method for producing same
Inventor: MURAISHI KAZUKI
IPC: H01G11/62
Filed: 2006-11-30
Abstract: Disclosed is an ionic liquid which contains an organic matter represented by the general formula (1) below as a cation component. This ionic liquid is stably in a liquid state over a wide temperature range while having excellent electrochemical stability. Consequently, the ionic liquid is useful for electrical storage devices, lithium secondary batteries, electric double layer capacitors, dye-sensitized solar cells, fuel cells, reaction solvents and the like.
Patent CA-2639295-A1 (CA)
Inventor: GRESHAM RICHARD D
IPC: A61B17/34
Filed: 2008-09-04
Abstract: A surgical portal assembly includes a portal adapted to provide access to underlying tissue and having a longitudinal opening extending along a longitudinal axis of the portal, and defining proximal and distal ends, and a seal. The seal comprises a gel material and a fabric material mounted relative to the gel material. The seal includes internal surfaces defining a passage for reception and passage of a surgical object in substantial sealed relation therewith. A fabric layer may be mounted adjacent each of proximal and distal surfaces of the seal. The internal surfaces defining the passage of the seal may include the gel material whereby the gel material establishes the sealed relation with the surgical object. The seal includes an inner seal segment which may generally taper in a distal direction to define a general funnel configuration.  Alternatively, the seal includes an inner seal segment which defines a general sloped portion to facilitate insertion of the surgical object and possibly minimize potential of inversion of the inner seal area upon withdrawal of the surgical object. The seal may include at least one support collar mounted adjacent a periphery of the seal element. The seal may further include an elastomeric material having a rigidity greater than the rigidity of the gel material.
Patent CA-2639448-A1 (CA)
Inventor: SULLIVAN JOHN
IPC: B61H9/00
Filed: 2008-09-10
Abstract: The present interface system includes a controller monitoring pressure on a locomotive brake pipe port, controlling pressure on a train brake pipe port in response to the pressure on a locomotive brake pipe port, providing ECP commands on an ECP trainline via a train electrical terminal in response to the pressure on the locomotive brake pipe port, and providing electrical power on the ECP trainline via an train electrical trainline terminal from the locomotive electrical trainline terminal. The system includes a three position change over valve. The system also includes a wireless display unit which communicates via a transceiver with the controller and displays information from the controller to the operator remote from the interface system.
Patent CA-2644115-A1 (CA)
Title: Method for endothelial cell extraction from adipose tissues
Inventor: NIKLASON LAURA E
IPC: C12N5/00
Filed: 2007-03-07
Abstract: Adipose tissue has proven to serve as an abundant, accessible, and rich source of endothelial or vascular endothelial cells suitable for tissue engineering. We describe a detailed method for the isolation and purification of endothelial cells using purified enzymes and antibody-based selection. The cells can be obtained from liposuction procedures and used in vascular grafts.
Patent CA-2644425-A1 (CA)
Title: Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
Inventor: GOUTOPOULOS ANDREAS
IPC: A61P29/00
Filed: 2007-04-18
Abstract: The invention provides novel heteroaryl-substituted arylaminopyridine derivative MEK inhibitors of Formula (Ia) Formula (Ia) Such compounds are MEK inhibitors that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation. Also disclosed is the treatment of a hyperproliferative disease in mammals, and pharmaceutical compositions containing such compounds.
Patent CA-2644666-A1 (CA)
Inventor: HAGER PAUL M
IPC: G06F40/00
Filed: 2007-04-17
Abstract: Methods and systems for correcting transcribed text. One method includes receiving audio data from one or more audio data sources and transcribing the audio data based on a voice model to generate text data. The method also includes making the text data available to a plurality of users over at least one computer network and receiving corrected text data over the at least one computer network from the plurality of users. In addition, the method can include modifying the voice model based on the corrected text data.
Patent CA-2645003-A1 (CA)
Inventor: ELDRIDGE WILLIAM
IPC: C12N15/10
Filed: 2006-03-16
Abstract: Peptide stabilizer compounds are provided that in combination with a biologically active peptide, can increase the protease elimination half-time of the biologically active peptide in vivo. The peptide stabilizer compounds are preferably in the form of peptide sequences that confer resistance to proteolysis upon conjugated biologically active peptides. Also provided is a method for the selection of novel proteolysis resistant compounds from in vitro generated libraries, and pharmaceutical compositions comprising the stabilizer compounds identified thereby.
Patent CA-2645455-A1 (CA)
Inventor: NALIN DAVID R
IPC: A61K35/14
Filed: 2008-11-28
Abstract: A method immunizing an individual that minimizes the amount of antigen or attenuated organism needed and the number of doses and clinic visits required, while making possible polyvalent simultaneous immunizations. The method comprises the steps of obtaining a sample of blood.     Exposing at least a portion of this sample to at least one immunogenic antigen, attenuant or other immunogen.  Incubating the exposed sample under specified optimal conditions and introducing this exposed sample into the individual to effect immunization thereof. The method of the invention also provides a method of delivery of materials, other than antigens, throughout an individual's body such as therapeutic drugs, virus vectors, genes, DNA, RNA, isotopes, and other therapeutic substances. A method for the delivery of treatment material to an individual is also provided by this method.
Patent CA-2645940-A1 (CA)
Title: Controlled release formulation of tolterodine
Inventor: ARIELI DAFNA
IPC: A61K9/50
Filed: 2007-03-21
Abstract: The invention encompasses stable multiparticulate pharmaceutical compositions of tolterodine having at least one pharmaceutically acceptable excipient and at least two populations of multiparticulates each population having tolterodine or a salt thereof and the ratio of the populations is from 90:10 to 10:90 by weight, wherein after storage for 1 month at 40 °C and 75 % relative humidity the difference between the dissolution profile at 4 hours is no more than about 5 % when compared to the dissolution profile at the time of manufacture.
Patent CA-2646747-A1 (CA)
Inventor: MACNAMARA FRANCIS T
IPC: A61B1/00
Filed: 2006-12-13
Abstract: A shaft for a medical device includes an outer sheath and a flexible spiral wrap therein. The flexibility of the spiral wrap is modified by changing the width of the wraps of a spiral, the thickness of the wraps of a spiral, or the gap spacing of the spiral. The spacing between wraps is maintained by attaching the spiral wrap to the cover sheath that surrounds the spiral wrap at two or more locations.
Patent CA-2648161-A1 (CA)
Inventor: WILD HANS-PETER
IPC: G01N1/20
Filed: 2007-04-12
Abstract: A device (1) and a method are disclosed, for the metered removal of an amount of product from a cavity (2, 2a) with product running therein, in particular a pipeline. The device comprises a valve body (5), sealing an outlet opening (4) in the cavity (2a) and a metering chamber (9). According to the invention, such a device may be designed for sterile removal of a product by means of a metering chamber (9) arranged adjacent to the outlet opening (4) in the direction of flow and with a dedicated removal opening (10) and providing the metering chamber (9) with an ejection piston (14) which may be displaced coaxial to the valve body (5).
Patent CA-2648645-A1 (CA)
Title: Use of a cannabinoid cb1 receptor antagonist for preparation of drugs useful for the prevention and treatment of benign prostatic hypertrophy
Inventor: GUAGNINI FABIO
IPC: A61K31/454
Filed: 2007-06-01
Abstract: La présente invention a pour objet l'utilisation d'un antagoniste des récepteurs CB1 aux cannabinoïdes pour la préparation de médicaments utiles pour la prévention et le traitement de l'hypertrophie bénigne de la prostate.